Drugs / COH06
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05334329 | Jul 2022 → Jun 2027 expected | non-small cell lung carcinoma | University of California, Irvine | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COH06 | “The NK cells given in this study, COH06, will come from umbilical cord blood and will have a new gene put in them that makes them express PD-L1, and express and secrete IL-15.” NCT05334329 ↗ |
| Route | Intravenous | “COH06 IV” NCT05334329 ↗ |